Additionally, to better understand the connection between IDO1 and immunity, we used three methods to measure immune cells in the TME in pan-cancer, including EPIC, QUANTISEQ, MCP-counter (Additional file 1: Fig. S3). The gene discussed is IDO1; the disease is cancer.